November 7, 2024
TOPLINE: Patients treated for prostate cancer had higher rates of complications, including urinary and sexual issues, than a control group of men. Radiotherapy increases the risk […]
November 7, 2024
TOPLINE: About 1 in 6 women experience symptoms of postpartum depression (PPD) 2 months after cesarean delivery, with certain obstetric factors such as emergency cesarean delivery […]
November 7, 2024
TOPLINE: A phospholipid nanoemulsion–based ocular lubricant applied twice daily is well tolerated, improves the stability of tear film, and alleviates symptoms in patients with dry eye […]
November 7, 2024
TOPLINE: Levonorgestrel intrauterine devices (IUDs) are associated with significantly more reports of acne, alopecia, and hirsutism compared with copper IUDs, with some differences between the available […]
November 7, 2024
TOPLINE: Both infliximab and adalimumab are safe and effective in achieving remission in patients with severe mucocutaneous Behçet syndrome, with adalimumab demonstrating a quicker response time; […]
November 7, 2024
TOPLINE: The risk for breast induration is associated with the volume of irradiated breast tissue in patients aged 65 years or older, but not in those […]
November 7, 2024
TOPLINE: Luminopia, a software system approved by the US Food and Drug Administration to treat amblyopia by modifying TV shows and movies in virtual reality (VR) […]
November 7, 2024
TOPLINE: Hepatitis C virus (HCV) reinfection rates among people who inject drugs are high immediately after treatment in community settings, particularly among those reporting recent injection […]
November 7, 2024
TOPLINE: There is no significant association between the use of proton pump inhibitors (PPIs) and risk for cardiovascular events, a meta-analysis shows. However, patients with gastroesophageal […]